Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.11% | 6.32% | -11.37% | -15.77% | -18.88% |
| Total Depreciation and Amortization | 3.64% | 3.09% | 3.57% | 3.64% | 4.07% |
| Total Amortization of Deferred Charges | 20.69% | 17.86% | 10.71% | 19.23% | 7.41% |
| Total Other Non-Cash Items | 48.50% | 6.37% | 622.01% | 368.46% | 376.20% |
| Change in Net Operating Assets | 60.33% | 54.27% | 110.94% | 12.06% | -129.03% |
| Cash from Operations | 10.67% | 10.03% | 27.68% | 7.98% | -4.88% |
| Capital Expenditure | -7.94% | -15.10% | -21.63% | -25.03% | -22.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -183.48% | 58.51% | 79.34% | 68.94% | 79.73% |
| Divestitures | -84.40% | -7.69% | -35.40% | -35.56% | -42.73% |
| Other Investing Activities | -1,771.43% | 48.24% | 90.70% | 87.90% | 94.21% |
| Cash from Investing | -56.89% | -4.71% | -19.94% | -30.15% | -28.23% |
| Total Debt Issued | -47.29% | -59.32% | -72.54% | -89.31% | -14.14% |
| Total Debt Repaid | 31.84% | 37.23% | 8.49% | 91.99% | 26.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 45.56% | 41.48% | 56.69% | 34.63% | 14.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.23% | -1.86% | -2.99% | -3.01% | -4.65% |
| Other Financing Activities | 28.91% | -12.42% | -24.02% | -21.01% | -20.45% |
| Cash from Financing | 27.62% | -18.65% | -26.36% | -64.95% | 15.01% |
| Foreign Exchange rate Adjustments | 135.00% | 143.75% | 117.39% | 20.00% | -566.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.97% | -285.71% | 101.53% | -214.02% | -58.77% |